Effect of Roflumilast on Airway Blood Flow as an Expression of Airway Inflammation in COPD

Trial Profile

Effect of Roflumilast on Airway Blood Flow as an Expression of Airway Inflammation in COPD

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Oct 2015

At a glance

  • Drugs Roflumilast (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Oct 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
    • 02 Dec 2014 Two treatment arms have been added.(Placebo single dose and Roflumilast 500µg single dose) as reported by ClinicalTrials.gov record.
    • 02 Dec 2014 Planned number of patients changed from 40 to 30 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top